Cancer-Focused Research:

Our collaborative translational research focuses on using our human lung cancer biorepository to characterize regulatory Tcell populations (Tregs) and mast cells (MC) in human lung tumors and serum seeking to correlate the degree of inflammation and pro-inflammatory cytokine levels as potential biomarkers of cancer prognosis and/or as potential targets for therapeutic manipulation. We are also using our prospectively acquired clinical database to evaluate the effect common co-morbid diseases and their treatment (e.g. diabetes and hyperlipidemia) exert on lung cancer recurrence and survival following surgical treatment.